|
An endurant iis stent graft system was implanted during an unknown endovascular procedure.It was reported that the patient's wife called, stating they conducted yearly follow-ups, during which a slow endoleak was identified.It was noted that the patient exhibited no signs or symptoms, and an intervention was performed 7 years post implant.No cause of was provided.No additional clinical sequelae were provided and the patient is fine.
|
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: etlw1620c93e, serial/lot #: (b)(6), ubd: 02-jun-2016, udi#: (b)(4); product id: etlw1620c124e, serial/lot #: (b)(6), ubd: 30-aug-2015, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|